Terns Pharmaceuticals, Inc.
TERN
$52.63
$0.070.13%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 8.70M | 7.80M | 7.03M | 8.71M | 7.95M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 27.60M | 27.72M | 27.38M | 27.43M | 25.95M |
| Operating Income | -27.60M | -27.72M | -27.38M | -27.43M | -25.95M |
| Income Before Tax | -23.19M | -24.59M | -24.03M | -23.82M | -21.76M |
| Income Tax Expenses | 383.00K | 46.00K | 64.00K | 88.00K | 40.00K |
| Earnings from Continuing Operations | -23.57M | -24.64M | -24.09M | -23.91M | -21.80M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -23.57M | -24.64M | -24.09M | -23.91M | -21.80M |
| EBIT | -27.60M | -27.72M | -27.38M | -27.43M | -25.95M |
| EBITDA | -27.59M | -27.70M | -27.37M | -27.37M | -25.88M |
| EPS Basic | -0.24 | -0.27 | -0.26 | -0.26 | -0.24 |
| Normalized Basic EPS | -0.15 | -0.17 | -0.16 | -0.16 | -0.15 |
| EPS Diluted | -0.24 | -0.27 | -0.26 | -0.26 | -0.24 |
| Normalized Diluted EPS | -0.15 | -0.17 | -0.16 | -0.16 | -0.15 |
| Average Basic Shares Outstanding | 97.91M | 91.70M | 91.58M | 91.47M | 91.24M |
| Average Diluted Shares Outstanding | 97.91M | 91.70M | 91.58M | 91.47M | 91.24M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |